Human Recombinant CCL19 (MIP-3 beta), STEMCELL Technologies (CAT#: STEM-CT-0834-ZJF)

Chemokine ligand 19 (CCL19), also known as macrophage inflammatory protein-3 beta (MIP-3β), is a member of the CC chemokine family, which plays key roles in inflammatory responses, T cell activation, homeostasis, and development (Yan et al.). CCL19 is expressed in lymph nodes, thymus, and activated bone marrow stromal cells; it binds to C-C motif chemokine receptor 7 (CCR7) to induce migration of macrophages, T cells, and B cells (Gibejova et al.). Clinically, the expression of CCL19 is correlated to autoimmune diseases such as rheumatoid arthritis and cancer (Pickens et al.; Zhang et al.).

Alternatives Names: beta-chemokine exodus-3, CC chemokine ligand 19, ELC, Exodus-3, MIP-3β, SCYA19
Cell Type: B Cells, Macrophages, T Cells
Species: Human
Area of Interest: Immunology
Purity: ≥ 95%

Reliable Consistency: Guarantees uniformity and repeatability in various applications with endotoxin levels below 0.2 EU/μg.
Free of Animal Components: Completely devoid of any animal or human-derived elements.
Broad Selection: Offers a wide range of human, mouse, and rat cytokines available in multiple sizes.

Human Recombinant IL-1RA, ACF, STEMCELL Technologies
Human Recombinant gAdiponectin (gAcrp30), ACF, STEMCELL Technologies
Human Recombinant IL-34, STEMCELL Technologies
Human Recombinant ACE2 Protein, aa18-740 (HEK293-expressed), STEMCELL Technologies